Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
07/21/1998 | US5783518 Dye diffusion thermal transfer printing |
07/16/1998 | WO1998030569A1 Asymmetric synthesis and catalysis with chiral heterocyclic compounds |
07/16/1998 | WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
07/16/1998 | WO1998030539A1 Novel thiocarbamic acid derivatives |
07/16/1998 | WO1997048672A3 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
07/16/1998 | CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
07/15/1998 | EP0719263B1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
07/15/1998 | CN1187808A Optically active substituted pheynylalkylamine derivatives |
07/14/1998 | US5780676 Bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives |
07/14/1998 | US5780648 Benzothiophene compounds, and uses formulations thereof |
07/14/1998 | US5780647 2,4-Pentadienoic acid derivatives having retinoid-like biological activity |
07/14/1998 | US5780640 Process for the biotechnological preparation of L-thienylalanines in enantiomerically pure form from 2-hydroxy-3-thienylacrylic acids and their use |
07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
07/14/1998 | US5780483 IL-8 receptor antagonists |
07/14/1998 | US5780480 Thrombolytic agents, anticoagulants |
07/14/1998 | US5780470 Melatonergic indanyl piperazines |
07/14/1998 | CA2041113C Thienobenzodiazepine derivatives and their use as pharmaceuticals |
07/09/1998 | WO1998029877A1 Proton conductor in liquid form |
07/09/1998 | WO1998029399A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
07/09/1998 | WO1998029396A1 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
07/09/1998 | WO1998029389A1 Malononitrile-derivative anion salts, and their uses as ionic conducting materials |
07/09/1998 | WO1998029388A1 Perfluorinated amide salts and their uses as ionic conducting materials |
07/09/1998 | WO1998029387A1 Aminobutyric acid fungicides |
07/09/1998 | WO1998029384A1 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
07/09/1998 | WO1998029383A1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect |
07/09/1998 | WO1998029358A2 Surface modified carbonate materials |
07/09/1998 | DE19700097A1 3-Aminocarbonyl/3-Aminothiocarbonyl-substituierte 2-Benzoyl-cyclohexan-1,3-dione 3-Aminocarbonyl / 3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexane-1,3-diones |
07/09/1998 | DE19700019A1 Substituierte 2-Benzoyl-cyclohexan-1,3-dione Substituted 2-benzoyl-cyclohexane-1,3-diones |
07/09/1998 | CA2805188A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye |
07/09/1998 | CA2704986A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye |
07/09/1998 | CA2683826A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
07/09/1998 | CA2277014A1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect |
07/09/1998 | CA2276584A1 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
07/08/1998 | EP0852137A2 Cosmetic compositions containing a photostable UV-A filter |
07/08/1998 | EP0851850A1 SYNTHESIS OF $g(a)-CHLORO OR FLUORO KETONES |
07/08/1998 | EP0750611B1 Anilide derivatives as fungicides |
07/08/1998 | CN1187183A Process for hydrogenation of imines |
07/07/1998 | US5777150 Substituted amic acid derivatives |
07/07/1998 | US5777089 Nonlinear optical device, colored textile, printing ink |
07/07/1998 | US5776984 Prostaglandin synthase-2 inhibitors |
07/07/1998 | US5776983 Antidiabetic agents, obesity, gastrointestinal disorders |
07/07/1998 | US5776982 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals |
07/07/1998 | US5776981 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals |
07/07/1998 | US5776977 Arylcycloalkyl derivatives, their production and their use |
07/07/1998 | US5776974 Immunosuppressant compounds |
07/07/1998 | US5776933 Method of inhibiting protease |
07/07/1998 | US5776859 Sodium channel active novel compounds and related processes and bioassay techniques |
07/07/1998 | US5776699 Method of identifying negative hormone and/or antagonist activities |
07/02/1998 | WO1998028284A1 Process for the preparation of heteroaryl-phenylalanines |
07/02/1998 | WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
07/02/1998 | WO1998028275A1 Novel compounds with analgesic effect |
07/02/1998 | WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
07/02/1998 | WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
07/02/1998 | DE19757627A1 Azulenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die diese Verbindungen enthält Azulene derivatives, processes for their preparation and pharmaceutical composition containing these compounds |
07/02/1998 | CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |
07/01/1998 | EP0850933A1 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
07/01/1998 | EP0850932A1 Salts of heterocyclic anions and their uses as ionic conductive materials |
07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
07/01/1998 | EP0850921A1 Salts of malononitrile derived anions, and their uses as ionic conductive materials |
07/01/1998 | EP0850920A2 Salts of perfluorinated amides and their uses as ionic conductive materials |
07/01/1998 | EP0850232A1 Benzothiazolone derivatives |
07/01/1998 | EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
06/30/1998 | US5773594 Treating skin disorders, reducing side effects of other retinoids |
06/30/1998 | US5773465 Tartronic acids, their acetalic ethers and o-esters |
06/30/1998 | US5773459 Enzyme inhibitors of kinases and anticarcinogenic agents |
06/25/1998 | WO1998027081A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
06/25/1998 | WO1998027058A2 N-piperazin-1-ylphenyl-benzamide derivatives |
06/25/1998 | WO1998027053A1 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
06/25/1998 | WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
06/25/1998 | CA2275492A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
06/25/1998 | CA2274055A1 N-piperazin-1-ylphenyl-benzamide derivatives |
06/25/1998 | CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
06/24/1998 | EP0848957A1 Fas LIGAND SOLUBILIZATION INHIBITOR |
06/24/1998 | EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
06/24/1998 | EP0848703A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
06/24/1998 | EP0848701A1 O-benzyl oxime ether derivatives and their use in crop protection compositions |
06/24/1998 | EP0848700A1 Acylaminosalicylic acid amides and their uses as pesticides |
06/24/1998 | EP0848698A1 Fluorobutene acid amides |
06/24/1998 | EP0848697A1 Process for the hydrogenation of imines |
06/24/1998 | EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
06/24/1998 | CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same |
06/24/1998 | CN1038835C Isoparaffin-olefin alkylation |
06/23/1998 | US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with |
06/23/1998 | US5770453 Measuring any electrical properties change after or during exposuring a sample to a calixarenes |
06/18/1998 | WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
06/18/1998 | WO1998025918A1 Analgesic, anti-inflammatory and anti-thrombosis esters of nitrated cycloaliphatic alcohols |
06/18/1998 | WO1998025915A1 Fused heterocyclic benzenecarboxylic acid amide derivatives and pgd2 antagonists containing the same |
06/18/1998 | WO1998025893A1 Arylsulfonamides as phospholipase a2 inhibitors |
06/18/1998 | WO1998025883A1 Ketobenzamides as calpain inhibitors |
06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
06/18/1998 | WO1998025616A1 Leukotriene antagonists for cerebral focal stroke |
06/18/1998 | WO1998025601A1 Fibrinogen receptor antagonists |
06/18/1998 | WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation |
06/18/1998 | WO1998016522A3 Aminophenol derivates with fungicidal property |
06/18/1998 | CA2274908A1 Leukotriene antagonists for cerebral focal stroke |
06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
06/18/1998 | CA2274029A1 Fibrinogen receptor antagonists |
06/18/1998 | CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation |